<VariationArchive RecordType="classified" VariationID="830793" VariationName="NC_000011.10:g.(?_44107663)_(44108268_?)del" VariationType="Deletion" Accession="VCV000830793" Version="1" NumberOfSubmissions="1" NumberOfSubmitters="1" DateLastUpdated="2023-08-06" DateCreated="2020-04-15" MostRecentSubmission="2020-04-15">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="820369" VariationID="830793">
      <GeneList>
        <Gene Symbol="EXT2" FullName="exostosin glycosyltransferase 2" GeneID="2132" HGNC_ID="HGNC:3513" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>11p11.2</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="11" Accession="NC_000011.10" start="44095678" stop="44251962" display_start="44095678" display_stop="44251962" Strand="+" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="11" Accession="NC_000011.9" start="44117098" stop="44266979" display_start="44117098" display_stop="44266979" Strand="+" />
          </Location>
          <OMIM>608210</OMIM>
          <Haploinsufficiency last_evaluated="2020-06-23" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=EXT2">Sufficient evidence for dosage pathogenicity</Haploinsufficiency>
          <Triplosensitivity last_evaluated="2020-06-23" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=EXT2">No evidence available</Triplosensitivity>
        </Gene>
      </GeneList>
      <Name>NC_000011.10:g.(?_44107663)_(44108268_?)del</Name>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>11p11.2</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" forDisplay="true" AssemblyStatus="previous" Chr="11" Accession="NC_000011.9" innerStart="44129213" innerStop="44129818" display_start="44129213" display_stop="44129818" variantLength="606" />
      </Location>
      <HGVSlist>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000011.9" sequenceAccession="NC_000011" sequenceVersion="9" change="g.(?_44129213)_(44129818_?)del" Assembly="GRCh37">
            <Expression>NC_000011.9:g.(?_44129213)_(44129818_?)del</Expression>
          </NucleotideExpression>
        </HGVS>
      </HGVSlist>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NC_000011.10:g.(?_44107663)_(44108268_?)del AND Exostoses, multiple, type 2" Accession="RCV001031400" Version="1">
        <ClassifiedConditionList TraitSetID="622">
          <ClassifiedCondition DB="MedGen" ID="C1851413">Exostoses, multiple, type 2</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2019-02-17" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2019-02-17" NumberOfSubmissions="1" NumberOfSubmitters="1" DateCreated="2020-04-15" MostRecentSubmission="2020-04-15">
        <ReviewStatus>criteria provided, single submitter</ReviewStatus>
        <Description>Pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">15221792</ID>
        </Citation>
        <ConditionList>
          <TraitSet ID="622" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="5054" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Exostoses, multiple, type 2</ElementValue>
                <XRef ID="MONDO:0007586" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">EXOSTOSES, MULTIPLE, TYPE II</ElementValue>
                <XRef Type="MIM" ID="133701" DB="OMIM" />
                <XRef Type="Allelic variant" ID="608210.0001" DB="OMIM" />
                <XRef Type="Allelic variant" ID="608210.0004" DB="OMIM" />
                <XRef Type="Allelic variant" ID="608210.0006" DB="OMIM" />
                <XRef Type="Allelic variant" ID="608210.0007" DB="OMIM" />
                <XRef Type="Allelic variant" ID="608210.0002" DB="OMIM" />
                <XRef Type="Allelic variant" ID="608210.0003" DB="OMIM" />
                <XRef Type="Allelic variant" ID="608210.0005" DB="OMIM" />
                <XRef Type="Allelic variant" ID="608210.0013" DB="OMIM" />
                <XRef Type="Allelic variant" ID="608210.0014" DB="OMIM" />
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">EXT2</ElementValue>
                <XRef Type="MIM" ID="133701" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="public definition">Hereditary multiple osteochondromas (HMO), previously called hereditary multiple exostoses (HME), is characterized by growths of multiple osteochondromas, benign cartilage-capped bone tumors that grow outward from the metaphyses of long bones. Osteochondromas can be associated with a reduction in skeletal growth, bony deformity, restricted joint motion, shortened stature, premature osteoarthrosis, and compression of peripheral nerves. The median age of diagnosis is three years; nearly all affected individuals are diagnosed by age 12 years. The risk for malignant degeneration to osteochondrosarcoma increases with age, although the lifetime risk for malignant degeneration is low (~2%-5%).</Attribute>
                <XRef ID="NBK1235" DB="GeneReviews" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="2205" />
                <XRef ID="2205" DB="Office of Rare Diseases" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="keyword">Neoplasm</Attribute>
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301413</ID>
                <ID Source="BookShelf">NBK1235</ID>
              </Citation>
              <XRef ID="321" DB="Orphanet" />
              <XRef ID="C1851413" DB="MedGen" />
              <XRef ID="MONDO:0007586" DB="MONDO" />
              <XRef Type="MIM" ID="133701" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="2355960" SubmissionDate="2020-02-06" DateLastUpdated="2020-04-15" DateCreated="2020-04-15">
        <ClinVarSubmissionID localKey="6030759|MedGen:C1851413" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV001194706" DateUpdated="2020-04-15" DateCreated="2020-04-15" Type="SCV" Version="1" SubmitterName="Invitae" OrgID="500031" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2019-02-17">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">15221792</ID>
          </Citation>
          <Comment>This variant is a gross deletion of the genomic region encompassing exon 2 of the EXT2 gene, which includes the initiator codon. The 5' end of this event is unknown as it extends beyond the assayed region for this gene and therefore may encompass additional genes. The 3' boundary is likely confined to intron 1 of the EXT2 gene. This is expected to result in an absent or disrupted protein product. Deletion of exon 2 has been observed in an individual affected with multiple osteochondromas (PMID: 15221792). Loss-of-function variants in EXT2 are known to be pathogenic (PMID: 10679937, 19810120). For these reasons, this variant has been classified as Pathogenic.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Invitae Variant Classification Sherloc (09022015)</Attribute>
          <Citation>
            <ID Source="PubMed">28492532</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="EXT2" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000011.9:g.(?_44129213)_(44129818_?)del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">Multiple exostoses type 2</ElementValue>
            </Name>
            <XRef DB="MedGen" ID="C1851413" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB6933794</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="2355960" TraitType="Disease" MappingType="Name" MappingValue="Multiple exostoses type 2" MappingRef="Preferred">
        <MedGen CUI="C1851413" Name="Exostoses, multiple, type 2" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

